Opko Sees Huge Long-Term Impact From Prolor Deal

Aug. 21 (Bloomberg) -- Phillip Frost, chief executive officer of Opko Health Inc., talks about its share listing on the Tel Aviv Stock Exchange today and the acquisition of Israeli drugmaker Prolor Biotech Inc. He speaks with Elliott Gotkine on Bloomberg Television's "On the Move." (Source: Bloomberg)

Full Show: Bloomberg Best (09/30)
54:58 - A review of the week's top business stories from the U.S., Europe and Asia. (Source: Bloomberg)
  • Tackling Age Bias in Silicon Valley
  • Is the Tech IPO Drought Over?
  • What to Expect From Alphabet's Oct. 4 Product Event